|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
JnvdPqNaUGZAazWTwNN |
|
|
Marty |
¥ |
2018/06/29 |
ȸ |
1 |
|
this post is fantastic cytopharma online Yet perhaps the winds of change are blowing. Cantab Capital Partners has launched its Core Macro Fund with a â?1/2 and 10â? fee structure. The management fee of 0.5 percent (which does not cover back office costs – hedge funds do not typically quote total expense ratios) applies to those investing at least $50 million. Those investing less money will pay more, but still enjoy the 10 percent performance fee. It is hard to argue with Cantab Capital Partnersâ?s assertion that this is â?exceptionally low costâ? for institutional investors, not least when considering that the fund has daily liquidity and there are neither redemption penalties nor gating clauses. But for performance fee savvy investors, the fact that there is no hurdle rate cannot be ignored. And for those looking for signs of a revolution, Cantabâ?s other funds have not changed their fees to move in line with the new fund.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|